Efficacy of tenapanor in managing hyperphosphatemia and constipation in hemodialysis patients: A randomized controlled trial
Tenapanor improves stool consistency, reduces laxative use, and provides effective phosphorus control in hemodialysis patients and represents a promising alternative to conventional phosphate binders.
Authors
- Nodoka Sato
- Yuuki Takeda
- M. Iwagami
- Takao Konishi (ORCID: https://orcid.org/0000-0001-8429-631X)
- Toru Takatani
- Yasumasa Hitomi (ORCID: https://orcid.org/0000-0003-3850-248X)
- Yusuke Kouchi (ORCID: https://orcid.org/0000-0002-3434-1263)
- Naoki Suzuki (ORCID: https://orcid.org/0000-0002-9748-6777)
- H. Iwata
- Takahiro Konishi
- Masato Nishimura
- Akie Kabuto
- Fumi Sumino
Institutions
- Toujinkai Hospital (JP)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1371/journal.pone.0319319
- Citations
- 1
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.43